These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 33679725)

  • 1. Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker.
    Sorić Hosman I; Kos I; Lamot L
    Front Immunol; 2020; 11():631299. PubMed ID: 33679725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
    Maury CP; Wegelius O
    Int J Tissue React; 1985; 7(5):405-7. PubMed ID: 4055265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker.
    Hwang YG; Balasubramani GK; Metes ID; Levesque MC; Bridges SL; Moreland LW
    Arthritis Res Ther; 2016 May; 18(1):108. PubMed ID: 27188329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum amyloid A--an indicator of inflammation in ankylosing spondylitis.
    Lange U; Boss B; Teichmann J; Klör HU; Neeck G
    Rheumatol Int; 2000; 19(4):119-22. PubMed ID: 10836520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ratio of serum amyloid A to C-reactive protein is constant in the same patients but differs greatly between patients with inflammatory diseases.
    Saiki O; Uda H
    Scand J Immunol; 2022 Feb; 95(2):e13121. PubMed ID: 34796986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases.
    Benson MD; Cohen AS
    Arthritis Rheum; 1979 Jan; 22(1):36-42. PubMed ID: 103558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A protein (SAA) subtypes in acute and chronic inflammatory conditions.
    Maury CP; Ehnholm C; Lukka M
    Ann Rheum Dis; 1985 Oct; 44(10):711-5. PubMed ID: 3931569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum amyloid A in the assessment of early inflammatory arthritis.
    Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
    J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid precursors and amyloidosis in rheumatoid arthritis.
    Cunnane G; Whitehead AS
    Baillieres Best Pract Res Clin Rheumatol; 1999 Dec; 13(4):615-28. PubMed ID: 10652643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid precursors and amyloidosis in inflammatory arthritis.
    Cunnane G
    Curr Opin Rheumatol; 2001 Jan; 13(1):67-73. PubMed ID: 11148718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity.
    Chambers RE; MacFarlane DG; Whicher JT; Dieppe PA
    Ann Rheum Dis; 1983 Dec; 42(6):665-7. PubMed ID: 6651371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa.
    Akdogan N; Dogan S; Incel-Uysal P; Karabulut E; Topcuoglu C; Yalcin B; Atakan N
    Arch Dermatol Res; 2020 May; 312(4):255-262. PubMed ID: 31729595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
    Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis.
    De Beer FC; Mallya RK; Fagan EA; Lanham JG; Hughes GR; Pepys MB
    Lancet; 1982 Jul; 2(8292):231-4. PubMed ID: 6124669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammatory reaction and laboratory tests: serum amyloid A (SAA) protein].
    Yamada T
    Rinsho Byori; 1990 Mar; 38(3):249-54. PubMed ID: 2112209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation between C-reactive protein and serum amyloid A in patients with autoinflammatory diseases.
    Legger GE; Dermer CWE; Brunger AF; van Daele PLA; Nienhuis HLA
    Pediatr Rheumatol Online J; 2022 Nov; 20(1):106. PubMed ID: 36434581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
    Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
    J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute phase reactant serum amyloid A in inflammation and other diseases.
    Zhang Y; Zhang J; Sheng H; Li H; Wang R
    Adv Clin Chem; 2019; 90():25-80. PubMed ID: 31122611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.
    Gursky O
    Curr Atheroscler Rep; 2020 Sep; 22(11):69. PubMed ID: 32968930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid A (SAA) concentration varies among rheumatoid arthritis patients estimated by SAA/CRP ratio.
    Kokubun M; Imafuku Y; Okada M; Ohguchi Y; Ashikawa T; Yamada T; Yoshida H
    Clin Chim Acta; 2005 Oct; 360(1-2):97-102. PubMed ID: 15932751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.